As of 2025-07-07, the Relative Valuation of Creo Medical Group PLC (CREO.L) is (124.38) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 12.75 GBP, the upside of Creo Medical Group PLC based on Relative Valuation is -1075.5%.
The range of the Relative Valuation is (113.00) - (115.82) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.4x - 30.3x | 27.0x |
| Forward P/E multiples | 21.4x - 23.0x | 22.4x |
| Fair Price | (113.00) - (115.82) | (124.38) |
| Upside | -986.3% - -1008.4% | -1075.5% |
| Date | P/E |
| 2025-07-04 | -2.57 |
| 2025-07-03 | -2.53 |
| 2025-07-02 | -2.63 |
| 2025-07-01 | -2.63 |
| 2025-06-30 | -2.63 |
| 2025-06-27 | -2.66 |
| 2025-06-26 | -2.73 |
| 2025-06-25 | -2.68 |
| 2025-06-24 | -2.73 |
| 2025-06-23 | -2.78 |
| 2025-06-20 | -2.83 |
| 2025-06-19 | -2.63 |
| 2025-06-18 | -2.66 |
| 2025-06-17 | -2.66 |
| 2025-06-16 | -2.78 |
| 2025-06-13 | -2.73 |
| 2025-06-12 | -2.80 |
| 2025-06-11 | -2.94 |
| 2025-06-10 | -3.08 |
| 2025-06-09 | -3.20 |
| 2025-06-05 | -3.18 |
| 2025-06-04 | -3.18 |
| 2025-06-03 | -3.13 |
| 2025-06-02 | -3.08 |
| 2025-05-30 | -2.98 |
| 2025-05-29 | -2.83 |
| 2025-05-28 | -3.20 |
| 2025-05-27 | -2.73 |
| 2025-05-23 | -2.48 |
| 2025-05-22 | -2.38 |
| 2025-05-21 | -2.18 |
| 2025-05-20 | -2.02 |
| 2025-05-19 | -1.99 |
| 2025-05-16 | -2.01 |
| 2025-05-15 | -2.09 |
| 2025-05-14 | -2.04 |
| 2025-05-13 | -2.04 |
| 2025-05-12 | -2.02 |
| 2025-05-09 | -2.04 |
| 2025-05-08 | -2.04 |
| 2025-05-07 | -2.06 |
| 2025-05-06 | -2.13 |
| 2025-05-02 | -2.11 |
| 2025-05-01 | -2.11 |
| 2025-04-30 | -2.11 |
| 2025-04-29 | -2.23 |
| 2025-04-28 | -2.11 |
| 2025-04-25 | -1.94 |
| 2025-04-24 | -1.94 |
| 2025-04-23 | -1.90 |